2013. San Antonio Breast Cancer Symposium – Comparative efficacy of everolimus and exemestane versus chemotherapy for advanced breast cancer in terms of progression-free survival

Cope S, Zhang J, Smiechowski B et al. Comparative efficacy of everolimus and exemestane versus chemotherapy for advanced breast cancer in terms of progression-free survival. Cancer Res 2013;73(24 Suppl): Abstract nr P6-10-03. Presented at: San Antonio Breast Cancer Symposium; December 10, 2013; San Antonio, TX, USA.